60 Degrees Pharmaceuticals, Inc. (SXTP)
1.02
-0.06
(-5.56%)
USD |
NASDAQ |
Sep 01, 16:00
1.02
0.00 (0.00%)
After-Hours: 20:00
60 Degrees Pharmaceuticals Cash from Investing (Quarterly) : -0.086M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.086M |
| March 31, 2026 | 1.194M |
| December 31, 2025 | -1.370M |
| September 30, 2025 | -0.0255M |
| June 30, 2025 | -0.0517M |
| March 31, 2025 | 1.702M |
| December 31, 2024 | -0.0021M |
| September 30, 2024 | -1.747M |
| June 30, 2024 | -0.1306M |
| Date | Value |
|---|---|
| March 31, 2024 | -0.0098M |
| December 31, 2023 | -0.0666M |
| September 30, 2023 | -0.0279M |
| June 30, 2023 | -0.0181M |
| March 31, 2023 | -0.0033M |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | -0.0008M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Harrow, Inc. | -0.534M |
| ANI Pharmaceuticals, Inc. | -3.054M |
| Corcept Therapeutics, Inc. | -29.24M |
| Veru, Inc. | 1.802M |
| Johnson & Johnson | -1.11B |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.232M |
| Free Cash Flow | -9.063M |
| Free Cash Flow Per Share (Quarterly) | -0.8734 |
| Free Cash Flow to Equity (Quarterly) | -2.317M |
| Free Cash Flow to Firm (Quarterly) | -2.316M |
| Free Cash Flow Yield | -550.0% |